Rituxan (rituximab) - Roche
When Inflammation Overwhelms the Kidneys: Castleman Disease-Associated AKI and Secondary AA Amyloidosis (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO1253; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Steroids and rituximab were initiated, but the patient remained dialysis-dependent without hematologic improvement...In patients with unexplained systemic inflammation, lymphadenopathy, and renal dysfunction, Castleman disease with secondary AA amyloidosis should remain an important diagnostic consideration. When renal biopsy is not feasible, extra-renal tissue biopsy may provide sufficient diagnostic evidence." 
Acute Kidney Injury • Amyloidosis • Colorectal Cancer • Glomerulonephritis • Hematological Disorders • Hepatitis C • Hepatology • Infectious Disease • Inflammation • Nephrology • Rare Diseases • Renal Disease • Thrombocytopenia • IL6
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4560013
 
Alexandra C. Pico-Ramirez; Emily Vazquez Morales; Jesus Daniel Vega-Colon; Ileana E. Ocasio Melendez
 
Oct 2, 2026
 
Prev Next